GCG and pancreatic neuroendocrine tumor: Of note, we did not observe hypoglycemia in the proband despite the increased AGLP-1 levels, which is different from rare patients with GLP-1 and glucagon co-secreting pancreatic neuroendocrine tumor who displayed hyperinsulinemic hypoglycemia and the proliferation of β-cell (19, 20).